Heiner Wedemeyer

Research interests

Publications

• EASL recommendations on treatment of hepatitis C: Final update of the series☆

  Journal of Hepatology · 2020 · https://doi.org/10.1016/j.jhep.2020.08.018

• Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference‡

  Journal of Hepatology · 2019 · https://doi.org/10.1016/j.jhep.2019.11.003

• EASL Recommendations on Treatment of Hepatitis C 2018

  Journal of Hepatology · 2018 · https://doi.org/10.1016/j.jhep.2018.03.026

• Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma

  Journal of Hepatology · 2016 · https://doi.org/10.1016/j.jhep.2016.10.029

• ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis

  New England Journal of Medicine · 2014 · https://doi.org/10.1056/nejmoa1402869

• The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm

  Journal of Viral Hepatitis · 2014 · https://doi.org/10.1111/jvh.12248

• Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis

  JAMA · 2012 · https://doi.org/10.1001/jama.2012.144878

• Long-Term Efficacy of Tenofovir Monotherapy for Hepatitis B Virus-Monoinfected Patients After Failure of Nucleoside/Nucleotide Analogues

  Hepatology · 2009 · https://doi.org/10.1002/hep.23246

• Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus

  Hepatology · 2008 · https://doi.org/10.1002/hep.22251

• Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients

  Gastroenterology · 2004 · https://doi.org/10.1053/j.gastro.2004.08.002

Current projects

No projects listed.